The antibody-based pharmaceuticals resource library’s Podcast

What is antibody humanization? How to humanize an antibody? The definition and humanization process are illustrated by Creative Biolabs in this episode.

In the episode, Creative Biolabs will detailed the mechanism of antibody diversity—gene rearrangement and antibody sequencing service. We hope this episode can help you understand the principle of complicated antibody diversity. 

This episode introduces the De Novo Antibody Sequencing service provided by Creative Biolabs, which can distinguish leucine from isoleucine with 100% accuracy. This valuable breakthrough improves functional analysis and verification and cost-effectively builds a strong foundation for downstream applications.

Prostate cancer is the most common cancer among men and predominately affects elderly men with a higher incidence. Deregulated production and secretion of growth factors by stromal cells within the PCa microenvironment, as well as mutations in androgen signaling pathway components and further physiological modifications, potentially lead to systemic recurrence of prostate cancer, including the appearance of focal tumor in advanced stage. Optimizing early diagnosis and developing targeted therapy of pancreatic cancer are the key to improving the survival rate of patients. In the episode, we will give you a comprehensive introduction to prostate cancer and its signaling pathways, diagnostic markers, and targeted therapies, as well as Creative Biolabs' antibody-related products and services to help fully understand how important it is to optimize early diagnosis and develop targeted drugs.

Pancreatic cancer is one of the malignant tumors with strong invasiveness, high degree of deterioration, and low surgical resection rate in the digestive system. Optimizing early diagnosis and developing targeted therapy of pancreatic cancer are the key to improving the survival rate of patients. In the episode, we will give you a comprehensive introduction to pancreatic cancer and its signaling pathways, diagnostic markers, and targeted therapies, as well as Creative Biolabs' antibody-related products and services to help fully understand how important it is to optimize early diagnosis and develop targeted drugs.

Endometrial cancer is the most common female genital cancer in the developed world. In the United States of America, an estimated 2.8% of women will be diagnosed with this malignancy at some point in their lifetime. Therefore, in order to improve the benefit of screening and the survival rate of patients, it is very important to establish a system of early diagnosis and targeted therapy for endometrial cancer. In the episode, we will give you a comprehensive introduction to endometrial cancer and its signaling pathways, diagnostic markers, and targeted therapies, as well as Creative Biolabs' antibody-related products and services.

Thyroid cancer (TC) remains the most common endocrine malignancy worldwide and its incidence and mortality have increased steadily over the last four decades. Thyroid cancer is commonly diagnosed at a younger age than most other adult cancers. Therefore, in order to improve the benefit of screening and the survival rate of patients, it is very important to establish a system of early diagnosis and targeted therapy for thyroid cancer. In the episode, we will give you a comprehensive introduction to thyroid cancer and its signaling pathways, diagnostic markers, and targeted therapies, as well as Creative Biolabs' antibody-related products and services.

Creative Biolabs has archived professional academic reports and the latest scientific progress of immune cell-based therapies, by making it into a podcast column. Here is a brief introduction about lentiviral vector gene delivery system and its application in CAR-T cell construction.

Creative Biolabs has archived professional academic reports and the latest scientific progress of immune cell-based therapies, by making it into a podcast column. Today, we are going to share some basic knowledge about Chimeric Antigen Receptor or CAR technology and its applications in tumor therapy.

In this episode, we will introduce phages, phagemid structure, and the process of phage library construction and screening.